🦊/Companies

Biomeme

Philadelphia, US · Founded 2012 · Delaware corporation · 64 employees on LinkedIn · 4 known investors

Find your way into Biomeme

535 people in our graph share verified history with the Biomeme team — schools, employers, funds. One of them is your warm intro.

Imran Bashirunlockedknows Max Perelman · together at USWeb/CKS (overlapped)
knows the team · via 3M
knows the team · via University of Iowa
×7knows the team · via Council on Foreign Relations
knows the team · via JUCCCE - Joint US-China Collaboration on Clean Energy
knows the team · via Middlebury Institute of International Studies at Monterey

Biomeme develops a mobile molecular testing platform that brings laboratory-grade PCR diagnostics to the point of need, serving clinical partners and organizations that need real-time detection of biological threats and diseases. The company operates a vertically integrated facility spanning biology, engineering, software, and manufacturing.

Founders & leadership

Biomeme was founded in 2012 by Max Perelman, Marc DeJong, Jesse vanWestrienen, Marc DeJohn, and Jesse van Westrienen.

MPMax Perelman
Max Perelmanin𝕏Co-Founder / President and CEOMax Perelman is President and Chief Executive Officer of Biomeme, which develops a mobile molecular testing platform for point-of-care PCR diagnostics. He previously held roles spanning environmental consulting, documentary filmmaking, management consulting, and software development, with a decade of experience leading projects across Asia, and holds a BA from Cornell University and an MBA and MAIEP from the Monterey Institute of International Studies.
MD
Marc DeJongCo-founder
JVJesse vanWestrienen
Jesse vanWestrienenin𝕏Co-Founder & CTO
MDMarc DeJohn
Marc DeJohninCo-founder, Executive Vice President of Engineering2012–2023Marc DeJohn has 28 years of experience in applied sciences, including work in electrochemistry, acoustics, optics, fluidics, and robotics, with expertise in chemistry, biology, and engineering design. He has founded two companies, authored 23 patents, and led the design and development of four commercial instrument platforms, with extensive experience directing product development and manufacturing teams through regulatory compliance and production scaling.
JV
Jesse van WestrienenCo-founder
CWChris Woods
Chris WoodsinChief Medical Officer
KSKristy Stoudt
Kristy StoudtDirector of Regulatory Affairs
RSRaphael Shapiro
Raphael ShapiroDirector of Engineering
NSNate Shapiro
Nate ShapiroDirector of Medical Strategy
TBTiffany Bratton
Tiffany BrattonCLIA Laboratory Director

Investors · 4

Reported raises · per SEC filings

Form D private placements

$5.5M disclosed across 2 rounds · 2014–2017

$4.5MraisedMay 2017 · 35 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Max PerelmanExecutive Officer, Director
  • Marc DeJongExecutive Officer, Director
  • Jesse vanWestrienenExecutive Officer, Director
Offering amount
$5.2M
Amount sold
$4.5M
Minimum investment
$10K
First sale
Apr 2017
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$992.8KraisedJan 2014 · 19 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • Marc DeJohnExecutive Officer, Director
  • Max PerelmanExecutive Officer, Director
  • Jesse van WestrienenExecutive Officer, Director
Offering amount
$1.9M
Amount sold
$992.8K
Minimum investment
$10K
Sales commissions
$17.5K
Placement agents
Microventure Marketplace Inc.
First sale
Jan 2014
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Biomeme for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Biomeme do?
Biomeme develops a mobile molecular testing platform that brings laboratory-grade PCR diagnostics to the point of need, serving clinical partners and organizations that need real-time detection of biological threats and diseases. The company operates a vertically integrated facility spanning biology, engineering, software, and manufacturing.
Who founded Biomeme?
Biomeme was founded by Max Perelman, Marc DeJong, Jesse vanWestrienen, Marc DeJohn, Jesse van Westrienen in 2012.
Who are Biomeme's investors?
Biomeme's investors include Darco Capital, NextFab Ventures, Robin Hood Ventures, MicroVentures.
How much funding has Biomeme raised?
Biomeme has disclosed $5.5M raised across 2 rounds.
Where is Biomeme headquartered?
Biomeme is headquartered in Philadelphia, US.